Valuation: genOway

Market Cap 22.87M 26.33M 21.32M 19.59M 37.04M 2.5B 37.45M 251M 98.26M 1.25B 98.89M 96.73M 4.15B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.58M 34.07M 27.58M 25.34M 47.92M 3.24B 48.45M 325M 127M 1.62B 128M 125M 5.37B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
Current month+1.64%
1 month+2.48%
3 months+3.77%
6 months+1.22%
Current year-8.49%
1 week 2.4
Extreme 2.4
2.52
1 month 2.21
Extreme 2.21
2.63
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
1/20/22 Buy

Chief Executive Officer

12,500 0.1376%
11/17/21 Sell

Chief Executive Officer

5,000 0.0553%
11/13/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-20.26%-35.08% 26.33M
-0.29%-3.34%-0.36%+13.34% 48B
+6.03%+5.22%+420.33%+519.87% 41.13B
-2.21%-6.07%+24.87%+5.20% 37.56B
+2.94%-2.25%+6.15%+59.69% 35.91B
+1.98%+4.74%+12.19%+41.37% 29.86B
+0.47%-3.87% - - 16.12B
+0.31%+0.72%+32.99%+122.25% 16.05B
+1.22%+0.82%+3.90%+17.85% 13.76B
-0.98%-12.98%-4.82%-38.09% 12.1B
Average +0.88%-1.54%+52.78%+78.49% 25.05B
Weighted average by Cap. +1.28%-0.93%+82.40%+116.65%

Financials

2024 2025
Net sales 27.53M 31.71M 25.67M 23.58M 44.6M 3.02B 45.09M 303M 118M 1.51B 119M 116M 5B 28.6M 32.94M 26.67M 24.5M 46.33M 3.13B 46.84M 314M 123M 1.57B 124M 121M 5.19B
Net income 1.83M 2.11M 1.71M 1.57M 2.97M 201M 3M 20.12M 7.87M 100M 7.92M 7.74M 332M 928K 1.07M 865K 795K 1.5M 102M 1.52M 10.2M 3.99M 50.81M 4.01M 3.92M 168M
Net Debt 623K 717K 581K 534K 1.01M 68.25M 1.02M 6.85M 2.68M 34.12M 2.69M 2.64M 113M 6.72M 7.74M 6.26M 5.75M 10.88M 736M 11M 73.85M 28.87M 368M 29.06M 28.42M 1.22B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-08-05 2.480 0.00% 2,320
26-08-04 €2.480 0.00% 8,522
26-08-03 €2.480 +1.64% 5,561
26-07-31 €2.440 0.00% 5,588
26-07-30 €2.440 -1.61% 4,991
  1. Stock Market
  2. Stocks
  3. ALGEN Stock